Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by Arrakis37on Oct 30, 2020 9:56am
106 Views
Post# 31812275

RE:RE:Oups

RE:RE:Oups

You're right stockman.  Thank you for your time to explain the mechanics behind the financing.  Very helpful.  

stockman6767 wrote: Arrakis, is that because you saw $5.50 in the new financing? That is the warrant exercise price not what they now paid for the new deal they are getting. They bought " 5,757,894 common shares, along with accompanying warrants to purchase one common share for each common share purchased by an investor, and 557,894 pre-funded warrants to purchase one common share, along with accompanying warrants to purchase one common share for each pre-funded warrant purchased by an investor." THUS
They got 5,757,894 + 557,894 = 6,315,788 shares for $30 M US thus they paid  $4.75 US per share if you assume the warrants have ZERO value which is not the case, so they actually paid well UNDER $4.75 per share depending on how much value you give to the warrants.

 

<< Previous
Bullboard Posts
Next >>